Upper Respiratory Staph Step Combination (Deseret Biologicals, Inc.)
Welcome to the PulseAid listing for the Upper Respiratory Staph Step Combination drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Deseret Biologicals, Inc. |
| NON-PROPRIETARY NAME: | Staphylococcus Aureus, Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Streptococcus Viridans |
| SUBSTANCE NAME: | STAPHYLOCOCCUS AUREUS; KLEBSIELLA PNEUMONIAE; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; HAEMOPHILUS INFLUENZAE TYPE B; STREPTOCOCCUS VIRIDANS GRO |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2012-09-10 |
| END MARKETING DATE: | 2021-06-01 |
Upper Respiratory Staph Step Combination HUMAN OTC DRUG Details:
| Item Description | Upper Respiratory Staph Step Combination from Deseret Biologicals, Inc. |
| LABELER NAME: | Deseret Biologicals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 15; 12; 12; 12; 12; 12; 12([hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL) |
| START MARKETING DATE: | 2012-09-10 |
| END MARKETING DATE: | 2021-06-01 |
| PRODUCT ID: | 43742-0162_b4a49d19-6f51-4807-999e-3f13dfa3c9ba |
| PRODUCT NDC: | 43742-0162 |
| APPLICATION NUMBER: | |
Other STAPHYLOCOCCUS AUREUS; KLEBSIELLA PNEUMONIAE; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; HAEMOPHILUS INFLUENZAE TYPE B; STREPTOCOCCUS VIRIDANS GRO Pharmaceutical Manufacturers / Labelers:
